A multicenter team of researchers has identified an enzyme key to the survival and spread of glioblastoma cancer cells that is not present in healthy brain cells, making the enzyme therapy a promising target. “With this enzyme, we may have found…
EBC 46 Human Trials Destroy Tumors
Scientists at QIMR Berghofer Medical Research Institute have used an experimental drug produced from the seeds of a rainforest plant to cure solid cancer tumors in preclinical trials. The study led by Dr. Glen Boyle at QIMR Berghofer’s Cancer Drug Mechanisms…
Paradigm Kicks Off Genomic Profiling for Cancer Registry
Paradigm has announced they have initiated genomic testing for Pharmatech’s AccessPPM Cancer Registry. Pharmatech’s AccessPPM is a cancer registry designed to collect EMR data and genomic information to help best match cancer patients with targeted clinical trials. The AccessPPM program and…
Multiple Strains for Clinical Development to be tested with Cannabis Science
Cannabis Science Inc. (OTC-QB: CBIS), a U.S. Company specializing in cannabis formulation-based drug development and related consulting, announced that it has commenced production of multiple strains of cannabis and European Union certified hemp varieties to initiate scientific research to select the…